What is the global market size of Ablation Devices Market?

Global Ablation Devices Market size was valued at USD 7.93 billion in 2021 and is poised to grow from USD 8.6 billion in 2022 to USD 16.99 billion by 2030, growing at a CAGR of 8.5% in the forecast period (2023-2030).

What is the key driver of Global Ablation Devices Market?

Rising patient demand for minimally invasive treatments is anticipated to drive market growth.

What is the key market trend for Global Ablation Devices Market?

Untapped markets such as Asia-Pacific, Africa, and Latin America are expected to emerge as attractive markets because to the presence of promising ablation technologies, an increase in demand for minimally invasive therapies, and an increase in disposable incomes. Furthermore, a large undiagnosed patient population, fast urbanization, which leads to an increase in chronic illness cases, greater awareness about prostate cancer, and enhanced government funding for healthcare are projected to contribute to market expansion in these regions.

Which region accounted for the largest share in Global Ablation Devices Market?

In 2021, the North American market accounted for more than 40% of the total revenue in the ablation devices industry. The rising frequency of cancer and other chronic illnesses, as well as the growing elderly population, are some of the primary drivers driving regional market expansion. According to the American Cancer Society, around 1.9 million new instances of cancer were recorded in the area in 2018, with roughly 693,000 deaths.

Top Ablation Devices Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Ablation Devices Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Ablation Devices industry players.

Ablation Devices Market Competitive Landscape

The ablation devices market is expanding steadily as the prevalence of heart illnesses such as atrial fibrillation (AF), atrial flutter, and cardiac arrhythmias rises. As a result, various mid-to-large-sized companies have increased their R&D efforts in this industry. Furthermore, even smaller companies have altered their focus and increased their R&D operations, resulting in a rise in product development (approvals & launches), and thereby contributing to the expansion of the ablation devices sector. In April 2016, Medtronic introduced the new Barrx 360 Express radiofrequency ablation balloon catheter, which is a self-adjusting circumferential RFA catheter used to eliminate damaged tissues. This catheter is expected to help with the treatment of Barrett's esophagus.

Ablation Devices Market Top Player’s Company Profiles

Medtronic
Boston Scientific
Abbott Laboratories
Johnson & Johnson
AngioDynamics
Atricure
Biosense Webster (a Johnson & Johnson company)
Olympus Corporation
Smith & Nephew
Stryker
St. Jude Medical (a subsidiary of Abbott Laboratories)
Varian Medical Systems
CONMED Corporation
EDAP TMS
Hologic
Intraop Medical
Merit Medical Systems
Neuwave Medical (a Johnson & Johnson company)
RF Medical
BTG International (a subsidiary of Boston Scientific)

Ablation Devices Market Recent Development

In September 2022, CLS Americas, a subsidiary of Clinical Laserthermia Systems AB, and Focalyx Technologies, a developer of image-guided fusion target devices, announced that they will exhibit and demonstrate their respective TRANBERGTM Thermal Therapy System for focal laser ablation and Focalyx Fusion medical device at the FOCAL 2022 Conference in Los Angeles, September 22-24, 2022. "Frontiers in Oncologic Prostate Care and Ablative Local Therapy" is the conference theme.
In November 2021, Medtronic launched Arctic Front Cardiac Cryoablation Catheter System in India used for the treatment of atrial fibrillation (AF). This has assisted the company in strengthening its product portfolio of ablation devices, thereby offering revenue growth opportunities in the market.

REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?

REQUEST FREE CUSTOMIZATION

FAQs

Global Ablation Devices Market size was valued at USD 10.42 Billion in 2024 and is poised to grow from USD 11.56 Billion in 2025 to USD 26.44 Billion by 2033, growing at a CAGR of 10.9% in the forecast period (2026–2033).

The global ablation devices industry is highly competitive, with several global and regional players actively investing in innovation, partnerships, and market expansion to strengthen their positions. Key players such as Medtronic, Boston Scientific Corporation, Johnson & Johnson (via Biosense Webster), Abbott Laboratories, and AngioDynamics are leading the charge with a focus on enhancing technological capabilities, expanding clinical applications, and penetrating emerging markets. 'Stereotaxis, Inc.', 'Medtronic', 'Boston Scientific Corporation', 'Biosense Webster, Inc. (Johnson & Johnson)', 'Abbott Laboratories', 'Stryker Corporation', 'AngioDynamics, Inc.', 'Covidien (now part of Medtronic)', 'Atricure, Inc.', 'Insightec Ltd.', 'Endocare, Inc. (Healthtronics)', 'Nevro Corp.'

The global surge in chronic conditions such as cancer, cardiovascular diseases, and neurological disorders is a major driver for the ablation devices market. As non-invasive and minimally invasive therapies gain preference, ablation procedures are increasingly used to treat conditions like atrial fibrillation, liver tumors, and spinal disorders. The demand is especially growing in aging populations, where surgery presents higher risks, making ablation a safer and faster alternative.

Integration of Artificial Intelligence for Precision and Efficiency: Artificial Intelligence (AI) is playing an increasingly transformative role in ablation therapy. In 2024, numerous ablation systems featured AI capabilities for real-time imaging analysis, automatic lesion detection, and personalized treatment planning. These tools enhance precision and help clinicians make faster, more accurate intraoperative decisions. For example, AI-powered platforms can differentiate between cancerous and healthy tissues in real-time, optimizing energy delivery during ablation. The ability to predict procedural outcomes and guide ablation paths reduces complications and improves long-term success rates.

As per regional forecast, North America holds a dominant region in the ablation devices market due to its robust healthcare infrastructure, high awareness levels, and early adoption of innovative medical technologies. The region benefits from well-established hospitals and cardiac care centers that are equipped to perform complex ablation procedures. A significant driver here is the growing prevalence of cardiac arrhythmias, particularly atrial fibrillation, which affects millions of people. Moreover, favorable reimbursement policies and strong investments in research and development by major players contribute to market growth.

Top Ablation Devices Companies

Ablation Devices Market Competitive Landscape

FAQs

What is the global market size of Ablation Devices Market?

Who are the key vendors in the Ablation Devices Market?

What is the key driver of Ablation Devices Market?

What is the key market trend for Ablation Devices Market?

Which region accounted for the largest share in Ablation Devices Market?

Request Free Customization